Using obesity drugs According to the Centers for Disease Control and Prevention, more than 100 million adults in the U.S
Call today to make an appointment at our Schaumburg, IL, office
Novo Nordisk (NYSE: NVO) is taking it on the chin this morning, after revealing the latest clinical trial results for weight loss using its CagriSema drug (a 50-50 mix of amylin analog cagrilintide and Novo's glucagon-like peptide-1 (GLP-1) receptor agonist)
Standard scales cant differentiate between fat, muscle, water weight, undigested food in your stomach, or discount the clothes youre wearing
As a result, a lot of undigested sugar particles end up in your intestines
This makes it particularly important for consumers to approach their use thoughtfully and with realistic expectations